Literature DB >> 21475550

Molecular genetics of Psoriasis (Principles, technology, gene location, genetic polymorphism and gene expression).

Ahmad A Al Robaee1.   

Abstract

Psoriasis is a common inflammatory skin disease with an etiology bases on both environmental and genetic factors. As is the case of many autoimmune diseases its real cause remains poorly defined. However, it is known that genetic factors contribute to disease susceptibility. The linkage analysis has been used to identify multiple loci and alleles that confer risk of the disease. Some other studies have focused upon single nucleotide polymorphisms (SNPs) for mapping of probable causal variants. Other studies, using genome-wide analytical techniques, tried to link the disease to copy number variants (CNVs) that are segments of DNA ranging in size from kilobases to megabases that vary in copy number. CNVs represent an important element of genomic polymorphism in humans and harboring dosage-sensitive genes may cause or predispose to a variety of human genetic diseases. The mechanisms giving rise to SNPs and CNVs can be considered as fundamental processes underlying gene duplications, deletions, insertions, inversions and complex combinations of rearrangements. The duplicated genes being the results of 'successful' copies are fixed and maintained in the population. Conversely, many 'unsuccessful' duplicates remain in the genome as pseudogenes. There is another form of genetic variations termed copy-neutral loss of heterozygosity (LOH) with less information about their potential impact on complex diseases. Additional studies would include associated gene expression variations with either SNPs or CNVs. Now many genetic techniques such as PCR, real time PCR, microarray and restriction fragment length analysis are available for detecting genetic polymorphisms, gene mapping and estimation of gene expression. Recently, the scientists have used these tools to define genetic signatures of disease, to understand genetic causes of disease and to characterize the effects of certain drugs on gene expression. This review highlights the principles, technology and applications on psoriasis.

Entities:  

Keywords:  Cytokine; Genes; Psoriasis

Year:  2010        PMID: 21475550      PMCID: PMC3068834     

Source DB:  PubMed          Journal:  Int J Health Sci (Qassim)        ISSN: 1658-3639


  123 in total

Review 1.  IL-1 and IL-18 receptors, and their extended family.

Authors:  John E Sims
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

2.  High-throughput variation detection and genotyping using microarrays.

Authors:  D J Cutler; M E Zwick; M M Carrasquillo; C T Yohn; K P Tobin; C Kashuk; D J Mathews; N A Shah; E E Eichler; J A Warrington; A Chakravarti
Journal:  Genome Res       Date:  2001-11       Impact factor: 9.043

Review 3.  A new dimension for the human genome project: towards comprehensive expression maps.

Authors:  T Strachan; M Abitbol; D Davidson; J S Beckmann
Journal:  Nat Genet       Date:  1997-06       Impact factor: 38.330

4.  Increased interleukin-7 levels in the sera of psoriatic patients: lack of correlations with interleukin-6 levels and disease intensity.

Authors:  J C Szepietowski; E Bielicka; P Nockowski; A Noworolska; F Wasik
Journal:  Clin Exp Dermatol       Date:  2000-11       Impact factor: 3.470

5.  Haplotype sharing analysis identifies a retroviral dUTPase as candidate susceptibility gene for psoriasis.

Authors:  John Foerster; Ilja Nolte; Judith Junge; Marcel Bruinenberg; Susann Schweiger; Katja Spaar; Gerrit van der Steege; Claudia Ehlert; Marcel Mulder; Vera Kalscheuer; Elisa Blumenthal-Barby; Jennifer Winter; Petra Seeman; Markward Ständer; Wolfram Sterry; Gerard Te Meerman
Journal:  J Invest Dermatol       Date:  2005-01       Impact factor: 8.551

6.  The angiotensin-converting enzyme insertion/deletion and the endothelin -134 3A/4A gene polymorphisms in patients with chronic plaque psoriasis.

Authors:  Wolfgang Weger; Angelika Hofer; Peter Wolf; Yosuf El-Shabrawi; Wilfried Renner; Helmut Kerl; Wolfgang Salmhofer
Journal:  Exp Dermatol       Date:  2007-12       Impact factor: 3.960

7.  Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

Authors:  Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

8.  Chromosomal localization of human leukocyte, fibroblast, and immune interferon genes by means of in situ hybridization.

Authors:  J M Trent; S Olson; R M Lawn
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Association of psoriasis to PGLYRP and SPRR genes at PSORS4 locus on 1q shows heterogeneity between Finnish, Swedish and Irish families.

Authors:  Kati Kainu; Katja Kivinen; Marco Zucchelli; Sari Suomela; Juha Kere; Annica Inerot; Barbara S Baker; Anne V Powles; Lionel Fry; Lena Samuelsson; Ulpu Saarialho-Kere
Journal:  Exp Dermatol       Date:  2008-07-17       Impact factor: 3.960

10.  [Association of NAT2 polymorphism with risks to develop psoriasis and various dermatological diseases in Moscow population].

Authors:  Zh M Kozhekbaeva; O A Gra; V S Fadeev; I V Goldenkova-Pavlova; I M Korsunskaia; S A Bruskin; E E Agafonova; An L Piruzian; S A Surzhikov; T V Nasedkina
Journal:  Mol Biol (Mosk)       Date:  2009 Jan-Feb
View more
  2 in total

1.  Serum vascular endothelial growth factor, transforming growth factor β1, and nitric oxide levels in patients with psoriasis vulgaris: their correlation to disease severity.

Authors:  Abdel-Raheim M A Meki; Hani Al-Shobaili
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

2.  Serum prolactin levels in psoriasis vulgaris.

Authors:  Farhad Handjani; Nasrin Saki; Iman Ahrari; Mehdi Ebrahimi; Mohammad Mehdi Khorrami; Parastoo Nematollahi
Journal:  ISRN Dermatol       Date:  2014-02-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.